Clinical Trials on Shigella Infection in United Kingdom

Total 21120 results

Institut Pasteur

Completed

Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine

Shigella Infection

France, United Kingdom
PATH

Withdrawn

Safety, Immunogenicity and Efficacy Study of Inactivated Whole Cell Shigella Flexneri 2a Vaccine With and Without dmLT in Adults

Shigella Sonnei Dysenteries

United States
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Phase 2 Shigella Vaccine and Challenge

Immunisation | Shigella Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3

Shigella Infection

United States
University of Maryland, Baltimore

Active, not recruiting

Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122

Shigella Infection | Enterotoxigenic Escherichia Coli Infection

United States
University of Maryland, Baltimore
PATH

Terminated

Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb

Shigella

United States
University of Maryland, Baltimore

Completed

Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine

Shigella

United States
University of Maryland, Baltimore
PATH

Completed

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP

Shigella

United States
University of Maryland, Baltimore
PATH

Terminated

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa

Shigella

United States
PATH
United States Department of Defense; Children's Hospital Medical Center, Cincinnati

Completed

Dose-Finding Study of Lyophilized Shigella Sonnei 53G Challenge Strain

Healthy

United States
Oxford University Hospitals NHS Trust

Completed

Oral Versus Intravenous Antibiotics for Bone and Joint Infections (OVIVA B&J) (OVIVA)

Bone Infection | Joint Infection

United Kingdom
Portsmouth Hospitals NHS Trust
University of Portsmouth

Completed

Biofilm Composition as a Predictive Biomarker for Prosthetic Joint Infection (Biofilms)

Joint Infection

United Kingdom
Imperial College London

Completed

To Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-Infection

HIV Infections | HIV | Acute Hepatitis C

United Kingdom
Enanta Pharmaceuticals, Inc
hVIVO Services Limited

Recruiting

A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model

RSV Infection

United Kingdom
AiCuris Anti-infective Cures AG

Completed

Thorough QT/QTc of Pritelivir in Healthy Subjects

HSV Infection

United Kingdom
Enanta Pharmaceuticals, Inc
hVIVO Services Limited

Completed

A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model

RSV Infection

United Kingdom
Hvivo
GlaxoSmithKline

Completed

RSV Study in Adults 60 to 75 Years of Age

RSV Infection

United Kingdom
Imperial College London

Recruiting

The Impact of Age on Adaptive Immunity in Adults Infected With Respiratory Syncytial Virus (INFLAMMAGE)

RSV Infection

United Kingdom
Bavarian Nordic

Completed

Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults

RSV Infection

United Kingdom
Meissa Vaccines, Inc.
Hvivo

Completed

Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine

RSV Infection

United Kingdom
Alios Biopharma Inc.

Completed

A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model

Respiratory Syncytial Virus Infections

United Kingdom
Thirty Respiratory Limited

Withdrawn

PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT) (PREVENT)

Respiratory Tract Diseases | COVID-19 Respiratory Infection | Respiratory Viral Infection

United Kingdom
St George's, University of London

Completed

Understanding COVID-19 Infection in Pregnant Women and Their Babies (periCOVID)

Pregnancy Related | Corona Virus Infection | Breastfeeding | Neonatal Infection

United Kingdom
Pfizer

Completed

A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection

Respiratory Syncytial Virus Infections

United Kingdom
Chelsea and Westminster NHS Foundation Trust

Unknown

Evaluating Clinical Parameters of COVID-19 in Pregnancy (COpregVID)

COVID-19 | COVID-19 Infection | 2019 Novel Coronavirus Infection

United Kingdom
Janssen Sciences Ireland UC

Completed

Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection.

Respiratory Syncytial Virus Infections

United Kingdom
Great Ormond Street Hospital for Children NHS Foundation...
Imperial College London; Barts & The London NHS Trust; University of Cambridge; Imperial College Healthcare NHS Trust

Completed

Biomarkers of Acute Serious Illness in Children (BASIC)

Critical Illness | Children, Only | Infection, Mixed

United Kingdom
Nottingham University Hospitals NHS Trust

Terminated

Ursodeoxycholic Acid in C. Difficile Infection

Clostridioides Difficile Infection

United Kingdom
Barts & The London NHS Trust

Unknown

Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection

Clostridium Difficile Infection

United Kingdom
Pfizer

Completed

To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI)

Bacterial Infections | Complicated Infection

United Kingdom
Imperial College London

Terminated

Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19) (PREDICT-ILI)

RNA Virus Infections | Respiratory Tract Infections | Covid19 | Influenza | Infection, Bacterial | SARS (Severe Acute Respiratory Syndrome) | Respiratory Viral Infection | Infection Viral

United Kingdom
Imperial College London
Sense Biodetection Limited

Unknown

Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens (SIMPLIFI)

Enterovirus Infections | Respiratory Syncytial Virus Infections | Human Influenza | Rhinoviral Infections | Metapneumovirus Infection | Parainfluenzae Viral Infections

United Kingdom
University of Oxford

Completed

The Microbiology of Pleural Infection (TORPIDS)

Pleural Infection | Pleural Infection Bacterial

United Kingdom
St George's, University of London
Antibiotic Research UK

Recruiting

Neonatal Antimicrobial Resistance and Outcome (neoAMRO)

Neonatal Infection

United Kingdom
University College, London
Public Health England

Completed

COG-UK Project Hospital-Onset COVID-19 Infections Study (COG-UK HOCI)

Coronavirus Infection | Covid-19 | SARS-CoV 2 | Coronavirus | Nosocomial Infection

United Kingdom
University of Oxford

Active, not recruiting

RESCEU: Defining the Burden of RSV Disease

Respiratory Syncytial Virus Infections | RSV Infection

United Kingdom
Imperial College London
Wellcome Trust

Completed

The Development of a Human Model of Respiratory Syncytial Virus Infection

Respiratory Syncytial Virus Infections | Respiratory Viral Infections

United Kingdom
Chelsea and Westminster NHS Foundation Trust

Recruiting

PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs (PHENOTYPE)

COVID-19 | Corona Virus Infection | Coronavirus | 2019 Novel Coronavirus Infection | 2019nCoV

United Kingdom
Royal Marsden NHS Foundation Trust
St George's, University of London; Mologic Ltd; The Royal Marsden Cancer Charity and other collaborators

Completed

Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19) (CARDS)

Coronavirus Infection | Cancer | Infectious Disease

United Kingdom
Cell Medica Ltd
Technology Strategy Board, United Kingdom

Completed

Safety Study of ADV-specific T-cells in Paediatric Patients Post Allo-HSCT (ASPIRE)

ADV Infection Post Allo-HSCT

United Kingdom
Destiny Pharma Plc

Completed

Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)

Staphylococcal Infection

United Kingdom
Biota Pharma Europe Limited

Completed

Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study

Respiratory Syncytial Virus (RSV) Infection

United Kingdom
University of Edinburgh
Medical Research Council; ISLACARE LTD (12108076)

Completed

ImplementatioN of Remote Surgical wOund Assessment During the coviD-19 pandEmic (INROADE)

Surgical Site Infection

United Kingdom
Nitric BioTherapeutics, Inc

Terminated

Clinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA)

Skin Ulcers | Methicillin-resistant Staphylococcus Aureus Infection

United Kingdom
Imperial College London

Recruiting

Routinely Collected Clinical Data and Evaluation of Antimicrobial Target Attainment (DATATDM)

Pharmacokinetics | Drug-Related Side Effects and Adverse Reactions | Infections, Bacterial | Drug Monitoring

United Kingdom
Scynexis, Inc.
Inncelerex

Completed

ADME Study of [14C]-Ibrexafungerp in Healthy Male Subjects

Fungal Infection

United Kingdom
Liverpool School of Tropical Medicine
University of Oxford

Recruiting

Using BCG Vaccine to Understand Tuberculosis Infection (Pilot BCG CHIM)

Tuberculosis

United Kingdom
Imperial College London
Royal Free Hospital NHS Foundation Trust; Hvivo

Completed

SARS-CoV-2 Human Challenge Characterisation Study

COVID-19 | Covid19 | Corona Virus Infection | SARS-CoV Infection | Coronavirus

United Kingdom
Imperial College London

Completed

Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection

Liver Fibrosis

United Kingdom
University of Leeds
GlaxoSmithKline; AstraZeneca; Sanofi Pasteur, a Sanofi Company; BioMérieux; Da Volterra and other collaborators

Completed

COMBACTE-CDI Understanding the Burden of C. Difficile Infection (COMBACTE-CDI)

Clostridium Difficile Infection

United Kingdom

Clinical Trials on Shigella Infection in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations